(Q37319650)

19 August 2017

1 reference

title

Designer therapies for glioblastoma multiforme (English)

1 reference

19 August 2017

1 reference

Sith Sathornsumetee

1

1 reference

PubMed ID

18990124

19 August 2017

Jeremy N Rich

series ordinal

2

1 reference

PubMed ID

18990124

19 August 2017

language of work or name

English

0 references

publication date

1 October 2008

1 reference

Annals of the New York Academy of Sciences

19 August 2017

1 reference

19 August 2017

1142

1 reference

19 August 2017

108-132

1 reference

The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma.

19 August 2017

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1444.009

Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1444.009

EGFR tyrosine kinase domain mutations in human gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1444.009

In vitro responsiveness of glioma cell lines to multimodality treatment with radiotherapy, temozolomide, and epidermal growth factor receptor inhibition with cetuximab

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1444.009

Phase II pilot study of bevacizumab in combination with temozolomide and regional radiation therapy for up-front treatment of patients with newly diagnosed glioblastoma multiforme: interim analysis of safety and tolerability

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1444.009

VEGF trap in combination with radiotherapy improves tumor control in u87 glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1444.009

Uncovering therapeutic targets for glioblastoma: a systems biology approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1444.009

A phase I dose-escalation study of fractionated stereotactic radiosurgery in combination with gefitinib in patients with recurrent malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1444.009

STI571 (Gleevec) improves tumor growth delay and survival in irradiated mouse models of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1196%2FANNALS.1444.009

Genomic signatures to guide the use of chemotherapeutics.

21 January 2018

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1038/NM1491

Identifiers

DOI

10.1196/ANNALS.1444.009

1 reference

19 August 2017

1 reference

PubMed ID

18990124